Homeo AI Blog ยท 2026-10-11

Homeo AI vs RevisitPlus: Multi-Branch Operations or Case Review?

Compare Accucia RevisitPlus' configured multi-branch workflows, shared records, roles and offline sync with Homeo AI's focused narrative review copilot.

See Homeo AI in your workflow

Choose a time for a guided walkthrough, or open the app if you already have an account.

Book a call on Calendly - open the full scheduling calendar and choose the time that works for you.

Log in to the Homeo AI app - continue your saved case and follow-up workflow.

A 3-day trial is available only to first-time users who have not tried Homeo AI before.

Start with the rollout decision

Evaluate Accucia RevisitPlus when an established clinic needs a configured operating system across branches, reception, doctors, and administration. Evaluate Homeo AI when the operational system already serves those teams and the remaining need is source-transparent, practitioner-controlled review of completed case narratives. Buying a multi-branch rollout and buying a focused review copilot involve different acceptance tests and different organizational work.

The supplied evidence for 11 October 2026 includes Accucia's official product page, the Dr Tathed case study, privacy policy, and terms. The product page is titled RevisitPlus | Homeopathy Software for Multi-Branch Clinics. It describes a proven base product configured per clinic. "Proven" is the vendor's characterization; this comparison does not independently validate reliability, performance, implementation success, or clinical outcomes.

What configuration changes about procurement

RevisitPlus describes lead, reception, doctor, and administration workflows; one patient record across branches; WhatsApp; mobile offline sync; analytics; and role controls. Those are vendor capability statements. They provide a concrete shortlist for demonstrations, but do not establish that every clinic receives identical screens, permissions, reports, or rollout arrangements.

A configured base product asks the buyer to specify how the organization actually works. Which branch receives a new enquiry? Who turns it into an appointment? Which staff member can correct an administrative detail? What should a doctor see when a person visits another branch? Write these decisions down before accepting a demonstration that uses the vendor's preferred workflow.

The supplied evidence does not contain RevisitPlus pricing, delivery commitments, migration quantities, support terms, or a detailed change-request policy. Ask for an account-specific scope and commercial agreement. Separate the base product, agreed configuration, data preparation, staff training, acceptance, and future changes in that discussion. These are procurement categories to resolve, not claims about how Accucia currently charges.

Homeo AI's established positioning does not promise those multi-branch operating functions. It is a source-transparent, practitioner-controlled review copilot for completed narratives. Test it against that narrower job rather than treating it as an alternative reception, branch, analytics, or offline-sync system.

One record needs an agreed ownership model

The vendor's one-patient-record-across-branches claim addresses a familiar operational concern: information created in one location should remain available in the intended workflow elsewhere. A shared record claim does not settle duplicate resolution, simultaneous updates, branch-specific access, correction history, or which copy takes precedence after disconnected work. Ask for those rules explicitly.

For an established organization, the important artifact is a written set of ownership and update rules. Identify the authoritative record, the staff allowed to change each field, and the process for resolving inconsistent copies. Do not accept apparent consistency in a simple demonstration as proof that every branch transition or conflict is handled correctly.

Role controls also need a task-level specification. A receptionist, practitioner, and administrator should each be tested against the permissions the clinic approves. The existence of roles is not evidence that the default setup matches that approval. Ask how access is assigned, changed, and removed, and which evidence of those actions is available in the proposed configuration.

A synthetic cross-branch acceptance exercise

Use de-identified cases created entirely for software evaluation. Invent Branch Cedar, Branch Maple, and Test Record RP-01, without real people, contacts, appointments, health histories, prescriptions, or outcomes. All names and events below are fictional. The exercise measures an operational handoff, not treatment quality or a real clinic's performance.

Create an invented enquiry at Cedar, have a test receptionist convert it into a demonstration appointment, and ask a test doctor at Maple to open the intended shared record. Ask the administrator to locate the same event in the available reporting workflow. Keep an expected-results sheet showing the record identity, branch, task owner, and approved access at each step.

Next, introduce a second invented enquiry with similar spelling. Require the demonstration to show how staff identify a possible duplicate and how the agreed process avoids combining unrelated records. Do not assume automatic matching or merging exists. If the product requires a manual step, record it and decide whether that step fits the clinic's operating model.

Finally, attempt approved and prohibited tasks from each test role. For example, the clinic's synthetic permission sheet may allow reception to change a demonstration appointment time while reserving narrative acceptance to the practitioner. Compare the actual behavior with that sheet. These permissions are invented test requirements, not a description of RevisitPlus defaults.

Preserve the action sequence, visible results, unresolved gaps, and vendor explanations. A useful pass means that staff can complete the agreed cross-branch handoff and respect its access rules. It does not mean every configuration is safe or that a shared record improves clinical outcomes.

See the workflow live

Choose a time for a guided walkthrough, or open the app if you already have an account.

Book a call on Calendly - open the full scheduling calendar and choose the time that works for you.

Log in to the Homeo AI app - continue your saved case and follow-up workflow.

A 3-day trial is available only to first-time users who have not tried Homeo AI before.

Test offline sync where updates disagree

Mobile offline sync is a vendor claim that deserves a separate acceptance exercise. Ask the vendor to demonstrate the supported offline tasks and define the limits before disconnecting a test device. Do not presume that every desktop feature or record operation is available offline, or that synchronization follows a particular conflict-resolution algorithm.

Using only Test Record RP-01, disconnect a test mobile device through the approved demonstration procedure. Change an allowed administrative field locally while a connected test operator makes a conflicting change. Reconnect and observe what happens. Record which value is accepted, whether the conflict is visible, and whether staff can reconstruct the sequence without guessing.

Repeat with a second change that does not conflict. Then check the shared record from the other invented branch. The expected behavior must come from the agreed configuration and acceptance document. If an offline action is unsupported, mark it unsupported; do not turn silence or a delayed refresh into a claim of successful synchronization.

Before rollout, assign a person to resolve failures and define when staff should stop further changes to the demonstration record. That is a proposed operational safeguard. The supplied sources do not establish Accucia's actual escalation process, recovery timing, or support commitments.

Read the Dr Tathed case study as vendor evidence

Accucia's Dr Tathed case study can help frame questions about the product and implementation. It remains vendor-reported evidence. This article does not treat its narrative as an independent performance benchmark, proof of causation, or a guarantee that another clinic will obtain the same experience.

Ask which parts of the case study correspond to the proposed base product, which required configuration, and what conditions affected adoption. Request a demonstration tied to the clinic's own synthetic acceptance sheet. No numeric improvements or independently verified outcomes are supplied here, so there is no defensible productivity, revenue, reliability, or clinical-performance comparison to calculate.

Analytics and WhatsApp should also receive bounded tests. Use invented operational events to check whether a demonstrated report counts the intended branch activities. For messaging, use an approved test environment without real recipients and verify the intended trigger and content. Do not assume a report proves causation or that a communication feature establishes consent, delivery, or appropriate disclosure.

Keep review outside the rollout success metric

For the Homeo AI evaluation, create a separate completed fictional narrative that contains an uncertain statement followed by a correction. Ask a qualified reviewer to identify the original wording, inspect any supporting source used in the interpretation, and decide what can be accepted. Compare the accepted explanation with the correction rather than scoring the exercise by a remedy name or an imagined outcome.

This tests the source-transparent, practitioner-controlled review positioning without assuming a branch system, automatic integration, or a particular interface. If a clinic considers both products, specify how the practitioner would carry an accepted explanation into its authoritative record. A documented handoff is a requirement to investigate; an integration between Homeo AI and RevisitPlus is not established by this evidence.

Accucia's privacy and terms URLs are supplied, but the evidence does not establish every application-specific processing, retention, export, deletion, or support provision. Request the terms governing the configured service and the intended data flows. Apply the same scrutiny before actual use of Homeo AI. Neither positioning establishes hosting or compliance guarantees.

Decision: require a rollout acceptance packet

Choose a RevisitPlus trial when the organization needs shared branch operations and can define its reception, doctor, administration, permissions, and disconnected-work requirements. Require a written scope, configuration decisions, synthetic test results, named acceptance owners, and resolved commercial and data-handling questions before expanding the rollout. Start with a bounded demonstration and measure the gaps rather than relying on a polished case study.

Choose a Homeo AI trial when branch operations already work and the unresolved task is focused review of completed narratives. Assess source transparency and practitioner control directly. Its narrower positioning should not be presented as evidence that it can replace the configured operating system. Keep the operational acceptance packet and narrative-review findings separate so that success in one does not conceal a failure in the other.

Professional-safety boundary

Neither product replaces diagnosis, referral, an emergency-care decision, professional judgment, prescription, potency, dosage, or follow-up responsibility. These invented exercises provide no treatment advice, remedy recommendation, or clinical-efficacy evidence. Appropriate medical assessment must not be delayed by software output. Practitioners remain responsible for accepted reasoning; clinic leadership remains responsible for permissions, record ownership, rollout decisions, and authorized data use.

Official sources checked

Product facts reviewed 2026-10-11. Confirm current features, prices, source libraries, and terms with the vendor.

Ready to take the next step?

Choose a time for a guided walkthrough, or open the app if you already have an account.

Book a call on Calendly - open the full scheduling calendar and choose the time that works for you.

Log in to the Homeo AI app - continue your saved case and follow-up workflow.

A 3-day trial is available only to first-time users who have not tried Homeo AI before.